Researchers used embryonic stem cells to repair damaged nerve fibers in a rat model of Pelizaeus-Merzbacher disease. The study showed that transplanted cells can promote myelin sheath growth, potentially leading to improved function and clinical applications.
Researchers developed a transgenic mouse model of chronic liver disease caused by hepatitis B virus (HBV), enabling the study of immune responses and drug development. The model opens opportunities for scientists to test drugs in the liver and understand how HBV causes liver disease.
The Rosalind Russell New Arthritis Treatment Program at UCSF is testing innovative therapies targeting specific cells that promote inflammation and joint damage. Current clinical trials focus on rheumatoid arthritis and systemic lupus erythematosus, with promising results expected to lead to nationwide approval.
Researchers have successfully replicated human bone disorder McCune-Albright syndrome in mice using a novel animal model. The model utilizes a combination of normal and mutant stromal cells, which are mixed together before transplantation into immune-compromised mice.
A study of 228 diseased heart valves found organized, hard-bone tissue in 30 valves, suggesting an active process of calcification. The discovery could lead to the development of treatments to prevent or treat heart-valve disease and provide insights into rare disorders like fibrodysplasia ossificans progressiva.
Thomas Jefferson researchers discovered that lower levels of the tumor suppressor gene Rb2/p130 correlate with increased risk of returning disease and higher mortality in women with endometrial cancer. The study suggests a potential diagnostic test to guide treatment and improve patient outcomes.
Researchers discovered a genetic defect in ALL1 gene duplication that signals poor prognosis and shorter survival time in AML patients. Patients with this defect require aggressive treatment, including allogenic bone marrow transplant, to improve survival rates.
A nationwide effort to find genes that determine susceptibility to rheumatoid arthritis has been launched, with researchers collecting medical information and genetic material from 1,000 families. The project aims to identify genetic regions shared by affected siblings, which may contain genes involved in the disease.
Researchers have identified the genetic link to Griscelli disease, a rare autosomal recessive disorder characterized by partial albinism and immunologic abnormalities. The gene responsible for the condition is myosin-5a, which plays a crucial role in organelle transport within cells.